A detailed history of Two Sigma Investments, LP transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 39,465 shares of KOD stock, worth $218,241. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,465
Previous 124,411 68.28%
Holding current value
$218,241
Previous $292,000 64.73%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.2 - $3.25 $186,881 - $276,074
-84,946 Reduced 68.28%
39,465 $103,000
Q2 2024

Aug 14, 2024

BUY
$2.29 - $4.48 $126,073 - $246,641
55,054 Added 79.38%
124,411 $292,000
Q1 2024

May 15, 2024

SELL
$3.01 - $7.45 $793,863 - $1.96 Million
-263,742 Reduced 79.18%
69,357 $364,000
Q4 2023

Feb 14, 2024

BUY
$1.4 - $3.24 $278,325 - $644,124
198,804 Added 148.04%
333,099 $1.01 Million
Q3 2023

Nov 14, 2023

BUY
$1.8 - $7.49 $85,717 - $356,681
47,621 Added 54.94%
134,295 $241,000
Q2 2023

Aug 14, 2023

SELL
$4.3 - $9.48 $53,930 - $118,898
-12,542 Reduced 12.64%
86,674 $598,000
Q1 2023

May 15, 2023

SELL
$4.81 - $8.88 $369,172 - $681,548
-76,751 Reduced 43.62%
99,216 $615,000
Q4 2022

Feb 14, 2023

SELL
$6.52 - $8.05 $1.38 Million - $1.7 Million
-211,693 Reduced 54.61%
175,967 $1.26 Million
Q3 2022

Nov 14, 2022

BUY
$7.57 - $12.5 $1.14 Million - $1.88 Million
150,536 Added 63.48%
387,660 $3 Million
Q2 2022

Aug 15, 2022

SELL
$5.04 - $9.48 $3.79 Million - $7.13 Million
-752,451 Reduced 76.04%
237,124 $1.81 Million
Q1 2022

May 16, 2022

BUY
$7.09 - $89.45 $7.02 Million - $88.5 Million
989,575 New
989,575 $7.64 Million
Q4 2021

Feb 14, 2022

SELL
$80.85 - $128.49 $11.2 Million - $17.8 Million
-138,849 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$81.97 - $106.94 $8.95 Million - $11.7 Million
-109,138 Reduced 44.01%
138,849 $13.3 Million
Q2 2021

Aug 16, 2021

BUY
$77.2 - $126.54 $14.1 Million - $23.1 Million
182,288 Added 277.46%
247,987 $23.1 Million
Q1 2021

May 17, 2021

BUY
$110.45 - $164.47 $6.66 Million - $9.92 Million
60,299 Added 1116.65%
65,699 $7.45 Million
Q4 2020

Feb 16, 2021

SELL
$60.78 - $154.03 $1.07 Million - $2.71 Million
-17,563 Reduced 76.48%
5,400 $793,000
Q3 2020

Nov 16, 2020

SELL
$45.05 - $59.27 $2.78 Million - $3.65 Million
-61,604 Reduced 72.85%
22,963 $1.36 Million
Q2 2020

Aug 14, 2020

SELL
$42.74 - $66.25 $351,536 - $544,906
-8,225 Reduced 8.86%
84,567 $4.58 Million
Q1 2020

May 15, 2020

BUY
$38.18 - $73.95 $2.49 Million - $4.82 Million
65,225 Added 236.61%
92,792 $4.43 Million
Q4 2019

Feb 14, 2020

BUY
$13.9 - $76.65 $177,225 - $977,287
12,750 Added 86.05%
27,567 $1.98 Million
Q3 2019

Nov 14, 2019

BUY
$10.24 - $17.57 $151,726 - $260,334
14,817 New
14,817 $213,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $288M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.